Hospital Carlos Fernando Malzoni Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2017
NCT03147092
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now